Cagrilintide

Cagrilintide is a synthetic peptide analogue developed from the amylin peptide structure and modified with specific amino acid substitutions and a lipid-based component. Unlike native amylin, it serves as a specialized molecular model for studying amylin-related receptor activity and peptide signalling pathways involved in metabolic regulation.

It is a drug-development candidate investigated in metabolic and pharmacology research contexts, particularly obesity and energy regulation studies.

With its consistent synthetic composition and well-defined structure, cagrilintide is used in preclinical and clinical studies focused on metabolic disease, including mechanistic research on:

• Receptor binding
• Signalling mechanisms
• Peptide stability

It is primarily investigated within metabolic pharmacology and drug development programs.